Research and guidelines interpretation of neoadjuvant therapy for resectable pancreatic cancer,promising or lim-ited?
10.16139/j.1007-9610.2024.01.01
- VernacularTitle:可切除胰腺癌新辅助治疗的研究及指南解读,肯定还是否定?
- Author:
Taiping ZHANG
1
;
Guihu WENG
;
Yueze LIU
Author Information
1. 中国医学科学院北京协和医学院北京协和医院基本外科,北京 100730
- Keywords:
Resectable pancreatic cancer;
Neoadjuvant therapy;
Progress and controversies;
Standardized treatment
- From:
Journal of Surgery Concepts & Practice
2024;29(1):1-4
- CountryChina
- Language:Chinese
-
Abstract:
As a systemic disease,pancreatic cancer is highly malignant and has a high rate of recurrence and metastasis,which makes it particularly difficult in diagnosis,treatment and management.In recent years,with the concept of neoadjuvant therapy deeply rooted in the hearts of the people,the treatment of pancreatic cancer has increasingly emphasized the development of comprehensive and individualized treatment schemes in the whole process and multi-dimensional management of pancreatic cancer patients.However,there still remain many controversies about the application of neoadjuvant therapy for resectable pancreatic cancer.This review intended to discuss the hot topics and related controversies in the implementation of neoadjuvant therapy for patients with resectable pancreatic cancer based on domestic and foreign guidelines and the latest research progress,which may vastly promote the standardized application of neoadjuvant therapy for resectable pancreatic cancer.
